Recruiting
Radiomics of Intra-abdominal and Subcutaneous Adipose Tissue Predict the Efficacy of Bariatric Surgery (RISABS)
Using radiomics of intra-abdominal and subcutaneous adipose tissue and clinical features to predict the weight loss efficacy and remission of type 2 diabetes mellitus after bariatric surgery.
ClinicalTrials.gov IDNCT06169033
PhaseNot Applicable
Enrollment800
SponsorChina-Japan Friendship Hospital
Age16 Years
SexALL
Conditions studied
Obesity, Type 2 Diabetes Mellitus, Bariatric Surgery
About this study
Using radiomics of intra-abdominal and subcutaneous adipose tissue and clinical features to predict the weight loss efficacy and remission of type 2 diabetes mellitus after bariatric surgery.
Primary outcomes
- Area under curve (AUC) of the weight loss prediction model after 1 year (1 year)
- Area under curve (AUC) of the T2DM remission prediction model after 1 year (1 year)
Eligibility information
Inclusion Criteria:
* BMI\>27.5kg/m2; Type 2 diabetes mellitus; Patients who will undergo bariatric surgery
Exclusion Criteria:
* Patients without abdominal CT scan; Patients did not undergo sleeve gastrectomy or Roux-en-Y gastric bypass.
Study locations
- Yuntao Nie, Beijing, 100029 China
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.